Andrew von Eschenbach News
Most Popular Andrew von Eschenbach Story
Who are pharma's true VIPs?
You mean you don't know? Helpfully, a trade magazine has ranked them for you. The 40 most influential people in pharma--and they're not always the people you'd expect. In fact, FDA Commissioner Andy Read more...
Latest Headlines
- September 25, 2009
- September 24, 2009
- January 29, 2009
- December 16, 2008
- July 11, 2008
- June 13, 2008
- June 5, 2008
- May 23, 2008
- May 23, 2008
- May 20, 2008
- May 14, 2008
- May 1, 2008
- April 28, 2008
- April 23, 2008
- April 16, 2008
- April 8, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
